{"id":"https://openalex.org/W2744593776","doi":"https://doi.org/10.1200/jop.2017.021675","title":"Can Minimal Residual Disease Determination in Acute Myeloid Leukemia Be Used in Clinical Practice?","display_name":"Can Minimal Residual Disease Determination in Acute Myeloid Leukemia Be Used in Clinical Practice?","publication_year":2017,"publication_date":"2017-08-01","ids":{"openalex":"https://openalex.org/W2744593776","doi":"https://doi.org/10.1200/jop.2017.021675","mag":"2744593776","pmid":"https://pubmed.ncbi.nlm.nih.gov/28796964"},"language":"en","primary_location":{"id":"doi:10.1200/jop.2017.021675","doi":"https://doi.org/10.1200/jop.2017.021675","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jop.2017.021675","pdf_url":null,"source":{"id":"https://openalex.org/S131102849","display_name":"Journal of Oncology Practice","issn_l":"1554-7477","issn":["1554-7477","1935-469X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-100"],"host_organization":"https://openalex.org/P4310320068","host_organization_name":"American Society of Clinical Oncology","host_organization_lineage":["https://openalex.org/P4310320068"],"host_organization_lineage_names":["American Society of Clinical Oncology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Oncology Practice","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023296232","display_name":"Marlise Rachael Luskin","orcid":"https://orcid.org/0000-0002-5781-4529","observed_orcids":["https://orcid.org/0000-0002-5781-4529"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marlise R. Luskin","raw_affiliation_strings":["Dana-Farber Cancer Institute; and Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute; and Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071023119","display_name":"Richard Maury Stone","orcid":"https://orcid.org/0000-0002-7526-2633","observed_orcids":["https://orcid.org/0000-0002-7526-2633"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard M. Stone","raw_affiliation_strings":["Dana-Farber Cancer Institute; and Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute; and Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3886,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.35537791,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"13","issue":"8","first_page":"471","last_page":"480"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9309999942779541},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":1.0},{"id":"https://openalex.org/keywords/mrd-quantification","display_name":"MRD quantification","score":0.7429999709129333},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.8019999861717224},{"id":"https://openalex.org/keywords/prognostic-value","display_name":"prognostic value","score":0.8349999785423279},{"id":"https://openalex.org/keywords/predictive-value","display_name":"predictive value","score":0.9300000071525574},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.47200000286102295},{"id":"https://openalex.org/keywords/pcr","display_name":"PCR","score":0.6840000152587891},{"id":"https://openalex.org/keywords/multiparameter-flow-cytometry","display_name":"multiparameter flow cytometry","score":0.9929999709129333},{"id":"https://openalex.org/keywords/next-generation-sequencing","display_name":"next-generation sequencing","score":0.9829999804496765},{"id":"https://openalex.org/keywords/clinical-guidelines","display_name":"clinical guidelines","score":0.5289999842643738},{"id":"https://openalex.org/keywords/treatment-decision-making","display_name":"treatment decision-making","score":0.4729999899864197}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8803539276123047},{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.7690790891647339},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6485693454742432},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.6234328746795654},{"id":"https://openalex.org/C2776611710","wikidata":"https://www.wikidata.org/wiki/Q16888295","display_name":"Induction chemotherapy","level":3,"score":0.5832420587539673},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5439578890800476},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48401471972465515},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.4639328122138977},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.45448729395866394},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3920031189918518},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3607531487941742},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.32888591289520264},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.20163199305534363},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000090243","descriptor_name":"Nucleophosmin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003582","descriptor_name":"Cytogenetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004252","descriptor_name":"DNA Mutational Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009687","descriptor_name":"Nuclear Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D016133","descriptor_name":"Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018365","descriptor_name":"Neoplasm, Residual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050660","descriptor_name":"Core Binding Factors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D060828","descriptor_name":"Induction Chemotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1200/jop.2017.021675","doi":"https://doi.org/10.1200/jop.2017.021675","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jop.2017.021675","pdf_url":null,"source":{"id":"https://openalex.org/S131102849","display_name":"Journal of Oncology Practice","issn_l":"1554-7477","issn":["1554-7477","1935-469X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-100"],"host_organization":"https://openalex.org/P4310320068","host_organization_name":"American Society of Clinical Oncology","host_organization_lineage":["https://openalex.org/P4310320068"],"host_organization_lineage_names":["American Society of Clinical Oncology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Oncology Practice","raw_type":"journal-article"},{"id":"pmid:28796964","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28796964","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of oncology practice","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":80,"referenced_works":["https://openalex.org/W45100087","https://openalex.org/W990603645","https://openalex.org/W1492609361","https://openalex.org/W1608690818","https://openalex.org/W1781634362","https://openalex.org/W1810459172","https://openalex.org/W1823520599","https://openalex.org/W1920829940","https://openalex.org/W1948328750","https://openalex.org/W1963777403","https://openalex.org/W1971455987","https://openalex.org/W1977924848","https://openalex.org/W1981449355","https://openalex.org/W1984338974","https://openalex.org/W1984658294","https://openalex.org/W2005410572","https://openalex.org/W2007234423","https://openalex.org/W2007302457","https://openalex.org/W2007347792","https://openalex.org/W2021378114","https://openalex.org/W2021380995","https://openalex.org/W2026826794","https://openalex.org/W2028285013","https://openalex.org/W2047011631","https://openalex.org/W2061963364","https://openalex.org/W2068208386","https://openalex.org/W2071206691","https://openalex.org/W2073409515","https://openalex.org/W2074425311","https://openalex.org/W2082484676","https://openalex.org/W2084299345","https://openalex.org/W2088588477","https://openalex.org/W2096270095","https://openalex.org/W2097146973","https://openalex.org/W2097823874","https://openalex.org/W2104127840","https://openalex.org/W2104411649","https://openalex.org/W2104722860","https://openalex.org/W2107027906","https://openalex.org/W2107810465","https://openalex.org/W2109005340","https://openalex.org/W2113367077","https://openalex.org/W2118241155","https://openalex.org/W2120204058","https://openalex.org/W2124159210","https://openalex.org/W2125233997","https://openalex.org/W2128541003","https://openalex.org/W2129338773","https://openalex.org/W2138265677","https://openalex.org/W2138394378","https://openalex.org/W2144395887","https://openalex.org/W2147852317","https://openalex.org/W2148156623","https://openalex.org/W2153994826","https://openalex.org/W2158154670","https://openalex.org/W2158448264","https://openalex.org/W2159875685","https://openalex.org/W2161938647","https://openalex.org/W2163926478","https://openalex.org/W2168480534","https://openalex.org/W2169046713","https://openalex.org/W2170515966","https://openalex.org/W2172604937","https://openalex.org/W2193395909","https://openalex.org/W2202668672","https://openalex.org/W2214515641","https://openalex.org/W2238713843","https://openalex.org/W2276580523","https://openalex.org/W2318674152","https://openalex.org/W2344085448","https://openalex.org/W2412183643","https://openalex.org/W2412401607","https://openalex.org/W2419140434","https://openalex.org/W2474389367","https://openalex.org/W2499815426","https://openalex.org/W2514964903","https://openalex.org/W2558761368","https://openalex.org/W2559463313","https://openalex.org/W2559537906","https://openalex.org/W2586529912"],"related_works":["https://openalex.org/W2028231895","https://openalex.org/W4391752105","https://openalex.org/W4388655441","https://openalex.org/W2535631313","https://openalex.org/W2762460894","https://openalex.org/W2609856348","https://openalex.org/W2103152434","https://openalex.org/W2800305601","https://openalex.org/W2779510295","https://openalex.org/W4411227662"],"abstract_inverted_index":{"In":[0],"acute":[1],"myeloid":[2],"leukemia":[3],"(AML)":[4],"that":[5,67,81,156],"is":[6,14,80,83],"in":[7,24,34,118,166,177,184],"complete":[8],"remission,":[9],"minimal":[10],"residual":[11],"disease":[12,50,65,105],"(MRD)":[13],"presumed":[15],"to":[16,52,58,107,138],"be":[17],"present,":[18],"though":[19],"not":[20],"morphologically":[21],"evident.":[22],"Advances":[23],"diagnostics":[25],"now":[26],"permit":[27],"the":[28,88,112,139,146,154,158,173,178],"detection":[29],"and":[30,45,54,64,90,101,127,135,160],"quantification":[31],"of":[32,41,78,87,92,142,148,163,175,180],"MRD":[33,42,79,116,143,164,176],"AML":[35,149,183],"by":[36],"several":[37],"techniques.":[38],"The":[39],"level":[40],"after":[43],"induction":[44],"consolidation":[46],"therapy":[47],"correlates":[48],"with":[49,130,182],"sensitivity":[51,103],"chemotherapy":[53],"has":[55],"greater":[56],"power":[57],"predict":[59],"long-term":[60],"survival":[61],"than":[62],"patient":[63],"characteristics":[66],"are":[68],"available":[69],"at":[70],"diagnosis,":[71],"including":[72,120,188],"genetic":[73],"information.":[74],"A":[75],"unique":[76],"advantage":[77],"it":[82,190],"an":[84],"integrated":[85],"measure":[86],"impact":[89],"interaction":[91],"genetics,":[93],"epigenetics,":[94],"host":[95],"immune":[96],"milieu,":[97],"bone":[98],"marrow":[99],"environment,":[100],"drug":[102],"on":[104,133],"response":[106],"treatment.":[108],"Here,":[109],"we":[110,169],"review":[111,153],"main":[113],"techniques":[114,144],"for":[115,145,172],"assessment":[117,165],"AML,":[119],"polymerase":[121],"chain":[122],"reaction,":[123],"multiparameter":[124],"flow":[125],"cytometry,":[126],"next-generation":[128],"sequencing,":[129],"a":[131],"focus":[132],"method-specific":[134],"general":[136],"limitations":[137],"optimal":[140],"employment":[141],"determination":[147],"prognosis.":[150],"We":[151],"also":[152],"data":[155],"establish":[157],"prognostic":[159],"predictive":[161],"value":[162],"AML.":[167],"Finally,":[168],"provide":[170],"recommendations":[171],"use":[174],"care":[179],"patients":[181],"clinical":[185],"practice":[186],"today,":[187],"whether":[189],"should":[191],"influence":[192],"treatment":[193],"decisions.":[194]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-08-17T00:00:00"}